Items where authors include "Kalra, S."

Article

Young, C.A. orcid.org/0000-0003-1745-7720, Rog, D.J., Sharrack, B. et al. (6 more authors) (2024) Physical and psychological aspects of multiple sclerosis: revisiting the Multiple Sclerosis Impact Scale (MSIS-29). Multiple Sclerosis Journal, 30 (13). pp. 1630-1641. ISSN 1352-4585

Feigin, V.L., Abate, M.D., Abate, Y.H. et al. (1400 more authors) (2024) Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Neurology, 23 (10). pp. 973-1003. ISSN 1474-4422

Blackstone, J., Williams, T., Nicholas, J.M. et al. (59 more authors) (2024) Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK. BMJ Open, 14 (9). e086414. ISSN 2044-6055

Schumacher, A.E., Kyu, H.H., Aali, A. et al. (1833 more authors) (2024) Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. The Lancet, 403 (10440). pp. 1989-2056. ISSN 0140-6736

Bhattacharjee, N.V., Schumacher, A.E., Aali, A. et al. (1403 more authors) (2024) Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. The Lancet, 403 (10440). pp. 2057-2099. ISSN 0140-6736

Ferrari, A.J., Santomauro, D.F., Aali, A. et al. (1325 more authors) (2024) Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet, 403 (10440). pp. 2133-2161. ISSN 0140-6736

Vollset, S.E., Ababneh, H.S., Abate, Y.H. et al. (1417 more authors) (2024) Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021. The Lancet, 403 (10440). pp. 2204-2256. ISSN 0140-6736

Brauer, M., Roth, G.A., Aravkin, A.Y. et al. (1792 more authors) (2024) Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet, 403 (10440). pp. 2162-2203. ISSN 0140-6736

Naghavi, M., Ong, K.L., Aali, A. et al. (1997 more authors) (2024) Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet, 403 (10440). pp. 2100-2132. ISSN 0140-6736

Mensah, G.A., Fuster, V., Murray, C.J.L. et al. (1194 more authors) (2023) Global burden of cardiovascular diseases and risks, 1990-2022. Journal of the American College of Cardiology, 82 (25). pp. 2350-2473. ISSN 0735-1097

Young, C.A. orcid.org/0000-0003-1745-7720, Rog, D.J., Sharrack, B. et al. (6 more authors) (2023) Measuring disability in multiple sclerosis: the WHODAS 2.0. Quality of Life Research, 32 (11). pp. 3235-3246. ISSN 0962-9343

Young, C.A. orcid.org/0000-0003-1745-7720, Rog, D.J., Sharrack, B. et al. (33 more authors) (2023) Correlates and trajectories of relapses in relapsing–remitting multiple sclerosis. Neurological Sciences, 45 (5). pp. 2181-2189. ISSN 1590-1874